• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

安非他明在异喹胍代谢快和代谢慢的人群中的代谢氧化作用。

Metabolic oxidation of methaqualone in extensive and poor metabolisers of debrisoquine.

作者信息

Oram M, Wilson K, Burnett D, Al-Dabbagh S G, Idle J R, Smith R L

出版信息

Eur J Clin Pharmacol. 1982;23(2):147-50. doi: 10.1007/BF00545969.

DOI:10.1007/BF00545969
PMID:7140803
Abstract

The metabolism of methaqualone to the glucuronides of 5 C-monohydroxy metabolites and to the N-oxide has been studied in 2 groups of healthy young adults phenotyped as extensive and poor metabolisers of debrisoquine. No significant interphenotype differences were observed with respect to the excretion of any of the 6 metabolites. It is probable that the genetic regulation of the pathways leading to these metabolites is at a locus other than that which is responsible for the regulation of the oxidation of debrisoquine, guanoxan, phenacetin, phenytoin and sparteine.

摘要

在两组健康年轻成年人中研究了甲喹酮代谢生成5种C-单羟基代谢物的葡糖醛酸苷以及N-氧化物的情况,这两组成年人根据异喹胍代谢能力被表型分为快代谢型和慢代谢型。在这6种代谢物的排泄方面未观察到显著的表型间差异。导致这些代谢物生成的代谢途径的遗传调控位点可能不同于负责调控异喹胍、胍生、非那西丁、苯妥英和司巴丁氧化的位点。

相似文献

1
Metabolic oxidation of methaqualone in extensive and poor metabolisers of debrisoquine.安非他明在异喹胍代谢快和代谢慢的人群中的代谢氧化作用。
Eur J Clin Pharmacol. 1982;23(2):147-50. doi: 10.1007/BF00545969.
2
Metabolism of paracetamol and phenacetin in relation to debrisoquine oxidation phenotype.对乙酰氨基酚和非那西丁的代谢与异喹胍氧化表型的关系。
Eur J Clin Pharmacol. 1991;40(6):547-52. doi: 10.1007/BF00279967.
3
The relationship between debrisoquine oxidation phenotype and the pharmacokinetics and pharmacodynamics of propranolol.异喹胍氧化表型与普萘洛尔的药代动力学和药效学之间的关系。
Br J Clin Pharmacol. 1984 Jun;17(6):679-85. doi: 10.1111/j.1365-2125.1984.tb02403.x.
4
Lack of relationship between tolbutamide metabolism and debrisoquine oxidation phenotype.甲苯磺丁脲代谢与异喹胍氧化表型之间缺乏相关性。
Eur J Clin Pharmacol. 1987;33(4):397-402. doi: 10.1007/BF00637637.
5
Metabolism of almitrine in extensive and poor metabolisers of debrisoquine/sparteine.阿吗碱在异喹胍/鹰爪豆碱代谢快者和代谢慢者体内的代谢情况
Br J Clin Pharmacol. 1991 Jan;31(1):73-6. doi: 10.1111/j.1365-2125.1991.tb03859.x.
6
Pharmacogenetic covariation of defective N-oxidation of sparteine and 4-hydroxylation of debrisoquine.司巴丁N-氧化缺陷与异喹胍4-羟化的药物遗传学共变。
Eur J Clin Pharmacol. 1980 Feb;17(2):153-5. doi: 10.1007/BF00562624.
7
The genetic control of sparteine and debrisoquine metabolism in man with new methods of analysing bimodal distributions.运用分析双峰分布的新方法对人司巴丁和异喹胍代谢的遗传控制。
J Med Genet. 1983 Oct;20(5):321-9. doi: 10.1136/jmg.20.5.321.
8
Animal modelling of human polymorphic drug oxidation--the metabolism of debrisoquine and phenacetin in rat inbred strains.人类多态性药物氧化的动物模型——大鼠近交系中异喹胍和非那西丁的代谢
J Pharm Pharmacol. 1981 Mar;33(3):161-4. doi: 10.1111/j.2042-7158.1981.tb13740.x.
9
Evidence for the polymorphic oxidation of debrisoquine in the Thai population.泰国人群中异喹胍多态性氧化的证据。
Br J Clin Pharmacol. 1990 Feb;29(2):244-7. doi: 10.1111/j.1365-2125.1990.tb03627.x.
10
Stereoselective metabolism of metoprolol in Caucasians and Nigerians--relationship to debrisoquine oxidation phenotype.美托洛尔在白种人和尼日利亚人中的立体选择性代谢——与异喹胍氧化表型的关系。
Br J Clin Pharmacol. 1989 May;27(5):613-6. doi: 10.1111/j.1365-2125.1989.tb03424.x.

引用本文的文献

1
Physiological changes during the menstrual cycle and their effects on the pharmacokinetics and pharmacodynamics of drugs.月经周期中的生理变化及其对药物药代动力学和药效学的影响。
Clin Pharmacokinet. 1998 Mar;34(3):203-18. doi: 10.2165/00003088-199834030-00003.
2
The effect of age on the competitive C- and N-oxidative pathways of methaqualone in women.年龄对女性中安眠酮竞争性C-和N-氧化途径的影响。
Eur J Drug Metab Pharmacokinet. 1984 Oct-Dec;9(4):301-6. doi: 10.1007/BF03189680.
3
Clinical significance of the sparteine/debrisoquine oxidation polymorphism.

本文引用的文献

1
The effect of age on the hydroxylation of amylobarbitone sodium in man.年龄对人体中戊巴比妥钠羟化的影响。
Br J Clin Pharmacol. 1974 Feb;1(1):41-3. doi: 10.1111/j.1365-2125.1974.tb00204.x.
2
Influence of DH/DL alleles regulating debrisoquine oxidation on phenytoin hydroxylation.调控异喹胍氧化的DH/DL等位基因对苯妥英羟化作用的影响。
Clin Pharmacol Ther. 1981 Apr;29(4):493-7. doi: 10.1038/clpt.1981.68.
3
A family and population study of the genetic polymorphism of debrisoquine oxidation in a white British population.对英国白人人群中异喹胍氧化遗传多态性的家系及群体研究。
司巴丁/异喹胍氧化多态性的临床意义
Eur J Clin Pharmacol. 1989;36(6):537-47. doi: 10.1007/BF00637732.
J Med Genet. 1980 Apr;17(2):102-5. doi: 10.1136/jmg.17.2.102.
4
Deficient metabolism of debrisoquine and sparteine.异喹胍和鹰爪豆碱代谢缺陷。
Clin Pharmacol Ther. 1980 Apr;27(4):547-9. doi: 10.1038/clpt.1980.77.
5
Plasma kinetics of methaqualone in man after single oral doses.单次口服剂量后甲喹酮在人体中的血浆动力学。
Eur J Clin Pharmacol. 1973 Oct;6(3):187-90. doi: 10.1007/BF00558284.
6
Bioavailability of methaqualone.甲喹酮的生物利用度。
J Clin Pharmacol. 1973 Oct;13(10):391-400. doi: 10.1002/j.1552-4604.1973.tb00185.x.
7
Urinary excretion of c-hydroxy derivatives of methaqualone in man.人尿液中安眠酮c-羟基衍生物的排泄情况。
Xenobiotica. 1976 Feb;6(2):125-34. doi: 10.3109/00498257609151621.
8
Urinary excretion of methaqualone-N-oxide in man.人尿中安眠酮 - N - 氧化物的排泄情况。
Xenobiotica. 1976 Feb;6(2):113-24. doi: 10.3109/00498257609151620.
9
Methaqualone metabolism by rat liver microsomes.甲喹酮在大鼠肝脏微粒体中的代谢。
Res Commun Chem Pathol Pharmacol. 1976 Jan;13(1):27-39.
10
Inter- and intra-individual variation in the metabolism of methaqualone in man after a single oral dose.单次口服剂量后,人对甲喹酮代谢的个体间和个体内差异。
Eur J Clin Pharmacol. 1978 Jun 19;13(4):291-7. doi: 10.1007/BF00716365.